anmelden
Analysen von David Adlington
| 09.10.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 14.09.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 31.08.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 08.08.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 03.08.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 01.08.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 17.07.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 13.07.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 12.06.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 07.06.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 31.05.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 10.05.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 04.05.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 23.02.17 | Fresenius overweight | JP Morgan Chase & Co. | |
| 23.02.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 17.02.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 16.02.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 17.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 12.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 04.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 04.01.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 04.01.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 04.01.17 | Fresenius overweight | JP Morgan Chase & Co. | |
| 14.12.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 29.11.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 28.10.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 24.10.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 07.10.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 13.09.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 03.08.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 03.08.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 29.07.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 29.07.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 27.07.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 08.07.16 | Gerresheimer kaufen | JP Morgan Chase & Co. | |
| 29.04.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 12.04.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 08.04.16 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 08.04.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 08.04.16 | STADA Neutral | JP Morgan Chase & Co. | |
| 08.04.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 08.04.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 08.04.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 26.02.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 26.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 25.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
| 25.02.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
| 22.02.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 17.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
